Facility registration renewal is due biennially, with the first renewal deadline set for July 1, 2026, following initial registration by July 1, 2024. FDA charges no government fee for registration or listing, though foreign facilities must maintain a designated U.S. Agent, and pricing for compliance support varies by package; contact the brand directly for details.
Cosmetic facilities distributing products in the United States must renew FDA registration biennially, with the first renewal deadline set for July 1, 2026. FDA updated its Cosmetics Direct portal on February 11, 2026 to support this process. We guide manufacturers, processors, and foreign brand owners through registration, renewal, and US agent designation requirements under MoCRA.
Key Takeaways
- Manufacturers and processors must renew FDA facility registrations every two years, with first renewal deadline July 1, 2026.
- Non-US companies distributing cosmetics in America must designate a US Agent for MoCRA compliance and FDA communication purposes.
- FDA suspends facility registrations when cosmetic products pose reasonable health risks to US consumers or violate regulations.
- Cosmetics Direct electronic submission portal provides biennial registration renewal assistance for manufacturers meeting updated FDA requirements.
Why Does The 2026 MoCRA Deadline Matter?
Cosmetic facilities distributing products across the United States face a recurring compliance obligation, not a one-time filing. Federal law under the Modernization of Cosmetics Regulation Act (MoCRA) requires manufacturers and processors to renew their FDA facility registration every two years, and missing that window carries real consequences for market access. We guide domestic and foreign cosmetic companies through each renewal cycle so production and distribution never stall.
Facilities that met the original July 1, 2024 registration deadline now sit on a fast-approaching renewal date. Section 607(a)(2) of the Federal Food, Drug, and Cosmetic Act sets the biennial clock, and it does not pause for busy production schedules or supply chain disruptions.
What changed with FDA’s registration system in 2026?
FDA announced updates to its Cosmetics Direct electronic submission portal on February 11, 2026. The agency also released a revised user guide and additional filing instructions to help facilities complete the biennial renewal correctly. These changes affect how manufacturers submit updated facility information ahead of the deadline.
Who should prioritize renewal preparation now?
- Manufacturers and processors registered before July 1, 2024
- Foreign brand owners relying on a FDA registration agent to manage U.S. filings
- Start-ups launching new cosmetic lines for distribution nationwide
We work with clients across the country from our Coral Gables, FL office, preparing renewal filings before deadlines close and portal changes create confusion.
Who Must Renew Facility Registration By July 2026?
Manufacturers and processors distributing cosmetic products in the United States face a firm renewal deadline of July 1, 2026. Missing this date creates real exposure: a lapsed registration can undercut a company’s standing with FDA and complicate distribution across every U.S. market the brand serves. We help both domestic manufacturers and foreign brand owners meet this obligation without last-minute scrambling.
This renewal cycle traces directly back to the original registration deadline. FDA required cosmetic manufacturers and processors to register their facilities for the first time by July 1, 2024. Under the biennial structure Congress built into the law, that initial registration now comes due for renewal exactly two years later.
Why Does This Renewal Requirement Exist?
The renewal obligation comes from Section 607(a)(2) of the Federal Food, Drug, and Cosmetic Act, as amended by the Modernization of Cosmetics Regulation Act (MoCRA). Congress designed the two-year cycle to keep FDA’s facility data current rather than static. A company that registered once in 2024 cannot assume that filing covers it indefinitely.
Who typically falls under this renewal requirement:
- Domestic manufacturers producing finished cosmetic products for U.S. sale
- Processors that alter or repackage cosmetic products before distribution
- Foreign facilities manufacturing products bound for the U.S. market
- Contract manufacturers producing under a brand owner’s name
Foreign brand owners working through a fda registration agent should confirm renewal timing well ahead of the deadline. Coordination across time zones and documentation requirements often takes longer than domestic filings. We work with cosmetic companies nationwide and internationally to track these dates and file accurately before they lapse.
What Does FDA’s Cosmetics Direct Portal Require?
Cosmetics Direct requires manufacturers and processors distributing products in the United States to submit facility registrations. Product listings through FDA’s electronic system, now updated to support the recurring renewal cycle. FDA revised the portal, its user guide, and related submission instructions specifically to help facilities manage the biennial renewal requirement. We help clients across the cosmetics industry navigate these updated submission tools without missing a filing window.
Failing to keep registration current carries real regulatory weight. FDA retains authority to suspend a facility’s registration if the agency determines a manufactured or processed cosmetic product presents a reasonable probability of causing serious adverse health consequences. That suspension power extends beyond a single flagged product when the underlying failure appears widespread across the facility’s operations.
What Happens If a Facility’s Registration Gets Suspended?
Suspension carries immediate commercial consequences. Once FDA suspends a facility’s registration, distributing or selling cosmetic products from that facility becomes a prohibited act under federal law. Introducing or delivering those products into interstate commerce is barred outright, halting sales nationwide until the registration issue is resolved.
Given these stakes, we recommend treating Cosmetics Direct submissions as an ongoing compliance obligation, not a one-time filing. A qualified fda registration agent helps manufacturers, foreign brand owners, and start-ups:
- Prepare accurate initial registrations and product listings
- Track renewal deadlines tied to the biennial cycle
- Correct data errors before FDA flags a facility
- Respond promptly if suspension risk arises
Shehadeh Giannamore, PLLC serves cosmetic companies distributing into the United States, whether operations sit domestically or abroad. We manage Cosmetics Direct filings so clients avoid the commercial disruption that follows a lapsed or suspended registration.
Do Foreign Facilities Need A US Agent?
Yes. Cosmetic manufacturers and processors located outside the United States must designate a fda registration agent to handle communication with FDA. This requirement applies regardless of company size, whether a startup shipping its first product line to American retailers or an established brand expanding into the U.S. market. Skipping this step stalls registration and delays market entry.
FDA will not accept a foreign facility’s registration without a properly designated agent on file. That agent becomes the official contact point for agency correspondence, inspection notices, and compliance inquiries tied to the facility.
What does a US Agent actually do?
A U.S. Agent provides ongoing representation for the foreign facility, not a one-time filing service. Communication with FDA continues throughout the facility’s registration period, covering everything from routine updates to urgent compliance matters. Foreign brand owners depend on this representation to respond quickly when FDA reaches out, since delays in response often trigger further scrutiny.
Who can serve as a US Agent for a foreign cosmetic facility?
FDA requires the agent to maintain a physical U.S. presence and remain reachable for communication on the facility’s behalf. Many foreign manufacturers turn to firms with regulatory law backgrounds rather than general business services, given the legal weight of FDA correspondence.
Our firm handles facility registration and product listing services as part of a broader regulatory practice, alongside label review, ingredient compliance, and enforcement defense work. Foreign brand owners gain a single point of contact rather than juggling separate vendors for filing and legal strategy. That combination matters most when FDA correspondence requires both a fast response and sound legal judgment. Domestic distributors working with overseas manufacturers benefit too, since agent gaps can hold up an entire product launch.
What Should You Do Before The Deadline?
Preparation, not panic, protects a cosmetic brand’s ability to stay on U.S. shelves. FDA charges no government filing fee for MoCRA facility registration or product listing. Budget concerns should center on preparation, not agency costs. Manufacturers and processors distributing products in the United States still need a clear plan for compiling facility data, product listings, and supporting documentation well before renewal comes due.
We have guided food, beverage, dietary supplement, cosmetic, and OTC drug companies toward FDA compliance nationwide and internationally. That history informs how we structure pre-deadline reviews for cosmetic clients, whether based domestically or overseas.
What costs should we expect when preparing a renewal?
Renewal costs come from the service fees a compliance firm charges to prepare, submit, and manage the filing correctly, not from FDA itself. Firms vary in scope and pricing, so comparing what’s included matters as much as comparing rates.
Do we need help managing the registration paperwork?
Many foreign manufacturers rely on a U.S.-based FDA registration agent to handle facility registration accurately and communicate with the agency on their behalf. Domestic manufacturers benefit from that same structured review before a submission deadline arrives.
Before any renewal deadline, we recommend the following steps:
- Confirm current facility and product listing data is accurate and complete.
- Identify any ownership, address, or product formulation changes since the last filing.
- Review U.S. Agent designation requirements for facilities located outside the country.
- Build in time for legal review, not just data entry.
Clients can reach our firm seven days a week and expect a response within 24 hours. Early outreach gives cosmetic companies room to correct issues before a submission window closes.
FAQ
When is the first MoCRA renewal deadline?
The first facility registration renewal deadline falls on July 1, 2026, following initial registration by July 1, 2024. Renewals then recur every two years under Section 607(a)(2) of the Federal Food, Drug, and Cosmetic Act.
Do foreign facilities need a US Agent for MoCRA compliance?
Yes, foreign facilities distributing cosmetics in the United States must maintain a designated US Agent for MoCRA compliance and FDA communication purposes. This applies to foreign brand owners relying on an FDA registration agent to manage US filings.
What changed with the Cosmetics Direct portal in 2026?
FDA updated the Cosmetics Direct electronic submission portal on February 11, 2026, releasing a revised user guide and additional filing instructions. These changes affect how manufacturers submit updated facility information ahead of the renewal deadline.
Conclusion
In closing, MoCRA facility registration renewal and United States agent designation represent critical compliance obligations that demand timely attention and accurate documentation. Facilities and their appointed agents must remain vigilant regarding renewal deadlines and maintain current registrations to avoid enforcement action. Engaging experienced FDA regulatory counsel ensures your facility meets all statutory requirements. Positions your organization for continued lawful operation in the cosmetics marketplace.